These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 26614517)
1. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas. Losa M; Bogazzi F; Cannavo S; Ceccato F; Curtò L; De Marinis L; Iacovazzo D; Lombardi G; Mantovani G; Mazza E; Minniti G; Nizzoli M; Reni M; Scaroni C J Neurooncol; 2016 Feb; 126(3):519-25. PubMed ID: 26614517 [TBL] [Abstract][Full Text] [Related]
2. Effect of temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma. Syro LV; Scheithauer BW; Ortiz LD; Fadul CE; Horvath E; Rotondo F; Kovacs K Hormones (Athens); 2009; 8(4):303-6. PubMed ID: 20045804 [TBL] [Abstract][Full Text] [Related]
3. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M Eur J Endocrinol; 2010 Dec; 163(6):843-51. PubMed ID: 20870708 [TBL] [Abstract][Full Text] [Related]
4. Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. Ceccato F; Lombardi G; Manara R; Emanuelli E; Denaro L; Milanese L; Gardiman MP; Bertorelle R; Scanarini M; D'Avella D; Occhi G; Boscaro M; Zagonel V; Scaroni C J Neurooncol; 2015 Mar; 122(1):189-96. PubMed ID: 25555563 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. Bengtsson D; Schrøder HD; Andersen M; Maiter D; Berinder K; Feldt Rasmussen U; Rasmussen ÅK; Johannsson G; Hoybye C; van der Lely AJ; Petersson M; Ragnarsson O; Burman P J Clin Endocrinol Metab; 2015 Apr; 100(4):1689-98. PubMed ID: 25646794 [TBL] [Abstract][Full Text] [Related]
6. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature. Lizzul L; Lombardi G; Barbot M; Ceccato F; Gardiman MP; Regazzo D; Bellu L; Mazza E; Losa M; Scaroni C Pituitary; 2020 Aug; 23(4):359-366. PubMed ID: 32232709 [TBL] [Abstract][Full Text] [Related]
7. The role of temozolomide in the treatment of aggressive pituitary tumors. Liu JK; Patel J; Eloy JA J Clin Neurosci; 2015 Jun; 22(6):923-9. PubMed ID: 25772801 [TBL] [Abstract][Full Text] [Related]